Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 3398
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel | Dr. Kiran Kondabagil, Associate Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Re-purposing of approved drugs from DrugBank database for possible treatment for COVID-19 by targeting SARS-CoV-2 main protease | Prof Vikash Kumar Dubey, Professor, Indian Institute of Technology (BHU), Varanasi | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Development of host-directed anti-coronavirus agents | Dr. Naveen Kumar, Scientist, National Research Centre on Equines (NRCE), Hisar | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Identification of novel antiviral targets for COVID-19 | Prof G Subba Rao, Associate Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Discovery of structure-based antivirals against SARS-CoV2 targeting key viral genome replication enzymes | Dr Pravindra Kumar, Professor, Indian Institute of Technology (IIT), Roorkee | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Structural and mechanistic studies to understand SARS-CoV-2 ingress into human cells and its therapeutic intervention | Dr Jayanta Chatterjee, Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Development of functionalized inanimate surfaces with repurposable multi-targeted viricidal agents/drugs for preventive and cost-effective antiviral applications | Dr. Nagma Parveen, Department of Chemistry, Indian Institute of Technology (IIT), Kanpur | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Development of antiviral surface coatings to prevent the spread of infections caused by influenza virus | Dr. Jayanta Haldar, Associate Professor, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Viral decontamination |
| Development of formulations for viral decontamination of inanimate surfaces | Dr. B. S. Butola, Associate Professor, Indian Institute of Technology (IIT), New Delhi | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Viral decontamination |